AI in Pathology Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

The global AI in Pathology market was valued at USD 28.75 Million in 2025. It is poised to grow at a CAGR of 9.12% during the forecast period of 2026-2035, and reach USD 68.81 Million by 2035. The market growth is driven by rising demand for digital pathology, increasing adoption of AI-driven diagnostics, and growing need for accurate and faster disease detection. Advanced technologies such as computational pathology and histopathology AI are enhancing workflow efficiency and improving clinical decision-making outcomes through automated analysis and tissue classification.

Q1 2026 Market Updates

Geopolitical Impact of Iran, US, and Israel War on the AI in Pathology Market

United States: The AI in Pathology Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, with similar revisions across other markets as corporate CFOs apply caution in an inflationary, uncertain macroeconomic environment. Microsoft Azure and AWS reported investigating latency spikes at Middle Eastern data center nodes following missile strikes on Dubai and Doha infrastructure. Semiconductor and electronics supply chains routed through the Gulf region are experiencing disruption, with some production inputs stranded aboard ships unable to transit the Strait of Hormuz. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, reflecting corporate caution in an inflationary environment. Despite overall caution, AI-driven infrastructure investment continues to provide structural demand support. Despite spending caution, AI infrastructure investment continues to grow, with the current crisis reinforcing the case for advanced technology adoption to offset rising labor and materials costs.

Iran: Iran's domestic AI in Pathology sector has been effectively suspended by the conflict. US-Israeli strikes on industrial and civilian infrastructure across Tehran, Mashhad, Isfahan, and other major cities have disrupted all commercial activity. Power outages from attacks on electricity generation facilities have halted manufacturing operations, and the collapse of the commercial banking and logistics system has eliminated any residual trade flows. The broader humanitarian crisis, with over 1,900 casualties and 4,000+ civilian buildings damaged, has redirected the entire Iranian economy toward survival rather than production or consumption.

Israel: Israel's technology sector, a globally significant innovation hub for cybersecurity, semiconductors, AI, and various specialized verticals, is experiencing operational disruption as engineering teams are reduced by military reservist call-ups. Several Israeli companies supply components, software, and services to global AI in Pathology market participants. Business development activities have been suspended, and some operational timelines extended. However, Israel's proven resilience through previous conflict periods, and the continued operation of critical R&D programmes, suggests the disruption will be temporary rather than structural.

Key Takeaways

Government

• Relevant technology procurement agencies should assess exposure to Gulf-region cloud and semiconductor supply chains, ensuring critical government IT systems have geographic redundancy and are not dependent on disrupted Middle Eastern infrastructure.
• Policymakers should consider technology investment incentives to offset IDC's revised 11.4% U.S. IT spending growth forecast, preventing conflict-driven corporate caution from permanently deferring productive technology capital investment.
• Cybersecurity agencies should elevate threat assessment for government and critical infrastructure systems, as the Iran conflict has been accompanied by extensive cyber operations targeting energy, financial, and communication infrastructure.

Market

• IDC's downward revision of IT spending growth from 12.4% to 11.4% reflects genuine corporate caution, but the structural AI-driven investment cycle remains intact, with the conflict actually creating additional demand for automation, supply chain visibility, and remote operation technology.
• Microsoft Azure and AWS reports of latency spikes at Middle Eastern data center nodes are accelerating enterprise multi-region architecture adoption and geographic redundancy investments that strengthen Ethernet and cloud infrastructure demand.
• The ai in pathology market benefits from the conflict as a demand catalyst in customer-facing applications, as businesses managing supply chain complexity, customer inquiry volumes, and remote operations require scalable technology platforms at unprecedented scale.

Procurement

• Enterprise technology procurement teams should assess Gulf-region cloud infrastructure exposure and request vendor confirmation that critical SaaS and IaaS services have adequate geographic redundancy outside the conflict zone.
• IT procurement managers should advance planned technology deployments from discretionary to priority status where the platform addresses supply chain visibility, remote operations, or customer communication challenges created by the conflict.
• Technology buyers should review semiconductor and electronics supply chains for Gulf-adjacent manufacturing exposure, building buffer inventory for critical components that may face supply disruption.

Key Market Trends and Insights

• North America dominated the market, capturing over 40% of the total revenue share during the historical period.
• Based on component, the software segment led the market, accounting for approximately 51% share in the historical period.
• Based on end use, pharmaceutical and biotechnology companies held the largest share, contributing around 47% of the market during the historical period.

Market Size and Forecast

• Market Size (2025): USD 28.75 Million
• Projected Market Size (2035): USD 68.81 Million
• CAGR (2026-2035): 9.12%